Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Early Phase 1
2(50.0%)
4Total
N/A(2)
Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03066908Not ApplicableSuspended

Sinopsys Lacrimal Stent Study for Patients With Chronic Sinusitis or CRS

Role: lead

NCT03304951Not ApplicableCompleted

Sinopsys® Lacrimal Stent Indicated for Sinus Irrigation

Role: lead

NCT02240615Early Phase 1Completed

The Sinopsys Lacrimal Stent for Lacrimal System Repair in Epiphora

Role: lead

NCT02297243Early Phase 1Completed

Sinopsys Lacrimal Stent Indicated for Sinus Irrigation

Role: lead

All 4 trials loaded